2. Tomidokoro A, Miyata K, Sakaguchi Y, Samejima T, Tokunaga T, Oshika T. Effects of pterygium on corneal spherical power and astigmatism. Ophthalmology 2000;107:1568-1571. PMID:
10919910
3. Saw SM, Banerjee K, Tan D. Risk factors for the development of pterygium in Singapore: a hospital-based case-control study. Acta Ophthalmol Scand 2000;78:216-220. PMID:
10794261
4. Taylor HR, West SK, Rosenthal FS, Munoz B, Newland HS, Emmett EA. Corneal changes associated with chronic UV irradiation. Arch Ophthalmol 1989;107:1481-1484. PMID:
2803097
5. Mackenzie FD, Hirst LW, Battistutta D, Green A. Risk analysis in the development of pterygia. Ophthalmology 1992;99:1056-1061. PMID:
1495784
6. Al-Bdour M, Al-Latayfeh MM. Risk factors for pterygium in an adult Jordanian population. Acta Ophthalmol Scand 2004;82:64-67. PMID:
14982048
8. Panchapakesan J, Hourihan F, Mitchell P. Prevalence of pterygium and pinguecula: the Blue Mountains Eye Study. Aust N Z J Ophthalmol 1998;26 Suppl 1:S2-S5.
10. Wong TY, Foster PJ, Johnson GJ, Seah SK, Tan DT. The prevalence and risk factors for pterygium in an adult Chinese population in Singapore: the Tanjong Pagar survey. Am J Ophthalmol 2001;131:176-183. PMID:
11228292
11. Wu K, He M, Xu J, Li S. Pterygium in aged population in Doumen County, China. Yan Ke Xue Bao 2002;18:181-184. PMID:
15510751
12. Lu J, Wang Z, Lu P, Chen X, Zhang W, Shi K, et al. Pterygium in an aged Mongolian population: a population-based study in China. Eye (Lond) 2009;23:421-427. PMID:
17948037
13. Shiroma H, Higa A, Sawaguchi S, Iwase A, Tomidokoro A, Amano S, et al. Prevalence and risk factors of pterygium in a southwestern island of Japan: the Kumejima Study. Am J Ophthalmol 2009;148:766-771. PMID:
19664753
14. Ang M, Li X, Wong W, Zheng Y, Chua D, Rahman A, et al. Prevalence of and racial differences in pterygium: a multiethnic population study in Asians. Ophthalmology 2012;119:1509-1515. PMID:
22494631
15. Ma K, Xu L, Jie Y, Jonas JB. Prevalence of and factors associated with pterygium in adult Chinese: the Beijing Eye Study. Cornea 2007;26:1184-1186. PMID:
18043173
16. Nemesure B, Wu SY, Hennis A, Leske MC; Barbados Eye Studies Group. Nine-year incidence and risk factors for pterygium in the barbados eye studies. Ophthalmology 2008;115:2153-2158. PMID:
18930552
17. Rim TH, Nam J, Kim EK, Kim TI. Risk factors associated with pterygium and its subtypes in Korea: the Korean National Health and Nutrition Examination Survey 2008-2010. Cornea 2013;32:962-970. PMID:
23442251
20. Lu P, Chen X, Kang Y, Ke L, Wei X, Zhang W. Pterygium in Tibetans: a population-based study in China. Clin Experiment Ophthalmol 2007;35:828-833. PMID:
18173411
21. Song SJ, Youm DJ, Chang Y, Yu HG. Age-related macular degeneration in a screened South Korean population: prevalence, risk factors, and subtypes. Ophthalmic Epidemiol 2009;16:304-310. PMID:
19874110
24. Jin YH. A new LogMAR vision chart: Jin`s vision chart. J Korean Ophthalmol Soc 1997;38:2036-2044 (Korean).
25. Tan DT, Chee SP, Dear KB, Lim AS. Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision. Arch Ophthalmol 1997;115:1235-1240. PMID:
9338666
26. Cameron ME. Pterygium throughout the world. Springfield: Thomas; 1965. p 141-171.
27. Darrell RW, Bachrach CA. Pterygium among veterans. An epidemiologic study showing a correlation between frequency of pterygium and degree of exposure of ultraviolet in sunlight. Arch Ophthalmol 1963;70:158-169. PMID:
14060093
28. Anderson JR. A pterygium map. Acta Ophthalmol 1954;3:1631-1642.
29. Baron JA. Beneficial effects of nicotine and cigarette smoking: the real, the possible and the spurious. Br Med Bull 1996;52:58-73. PMID:
8746297
30. Peiretti E, Dessì S, Mulas C, Abete C, Norfo C, Putzolu M, et al. Modulation of cholesterol homeostasis by antiproliferative drugs in human pterygium fibroblasts. Invest Ophthalmol Vis Sci 2007;48:3450-3458. PMID:
17652712